亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer

医学 彭布罗利珠单抗 甲状腺 内科学 甲状腺癌 无症状的 危险系数 肺癌 甲状腺功能 抗甲状腺自身抗体 癌症 胃肠病学 肿瘤科 免疫疗法 抗体 置信区间 免疫学 自身抗体
作者
Juan C. Osorio,Ai Ni,Jamie E. Chaft,Rachael Pollina,Mary Kate Kasler,Daniel J. Stephens,C. Rodríguez Rodríguez,Lajhem Cambridge,Humaira Rizvi,Jedd D. Wolchok,Taha Merghoub,Charles M. Rudin,Stephanie Fish,Matthew D. Hellmann
出处
期刊:Annals of Oncology [Elsevier BV]
卷期号:28 (3): 583-589 被引量:601
标识
DOI:10.1093/annonc/mdw640
摘要

Programmed cell death protein-1 (PD-1) blockade therapies have demonstrated durable responses and prolonged survival in a variety of malignancies. Treatment is generally well tolerated although immune-related adverse events (irAEs) can occur. Autoimmune thyroid dysfunction is among the most common irAE, but an assessment of the clinical, mechanistic, and immunologic features has not been previously described.Patients with advanced non-small-cell lung cancer (NSCLC) treated with pembrolizumab at Memorial Sloan Kettering Cancer Center (n = 51) as part of KEYNOTE-001 (NCT01295827) were included. Thyroid function test and anti-thyroid antibodies were assessed prospectively at each study visit, beginning before the first treatment. Frequency of development of thyroid dysfunction, association with anti-thyroid antibodies, clinical course, and relationship with progression-free survival and overall survival to treatment with pembrolizumab was evaluated.Of 51 patients treated, 3 were hypothyroid and 48 were not at baseline. Ten of 48 [21%, 95% confidence interval (CI) 10% to 35%] patients developed thyroid dysfunction requiring thyroid replacement. Anti-thyroid antibodies were present in 8 of 10 patients who developed thyroid dysfunction, compared with 3 of 38 who did not (80% versus 8%, P < 0.0001). Thyroid dysfunction occurred early (median, 42 days) in the pembrolizumab course, and a majority (6 of 10 patients) experienced brief, transient hyperthyroidism preceding the onset of hypothyroidism; no persistent hyperthyroidism occurred. Both hyperthyroidism and hypothyroidism were largely asymptomatic. Overall survival with pembrolizumab was significantly longer in subjects who developed thyroid dysfunction (hazard ratio, 0.29; 95% CI 0.09-0.94; P = 0.04).Thyroid dysfunction during pembrolizumab treatment of NSCLC is common and is characterized by early-onset, frequently preceded by transient hyperthyroidism, closely associated with anti-thyroid antibodies, and may be associated with improved outcomes. The presence of antibody-mediated toxicity in T-cell-directed therapy suggests an under-recognized impact of PD-1 biology in modulating humoral immunity.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
时尚的映容完成签到,获得积分10
2秒前
UNIQUE完成签到 ,获得积分10
3秒前
闪闪的妖妖完成签到,获得积分10
7秒前
完美的睿渊完成签到,获得积分10
7秒前
乐康完成签到,获得积分10
9秒前
10秒前
15秒前
15秒前
书进1113完成签到,获得积分10
17秒前
米龙完成签到,获得积分10
19秒前
我是老大的应助被追寻从寒采纳,获得10
23秒前
qty完成签到 ,获得积分10
24秒前
lhh发布了新的文献求助10
24秒前
顺心醉柳完成签到 ,获得积分10
24秒前
25秒前
27秒前
31秒前
甜美幻露发布了新的文献求助30
33秒前
广州小肥羊完成签到 ,获得积分10
33秒前
ping发布了新的文献求助30
34秒前
34秒前
35秒前
GingerF的应助被OK采纳,获得100
36秒前
小蘑菇的应助被一期一会采纳,获得10
37秒前
Lu完成签到,获得积分10
38秒前
39秒前
wang完成签到 ,获得积分10
40秒前
43秒前
44秒前
研友_VZG7GZ的应助被小花采纳,获得10
44秒前
45秒前
45秒前
学学半完成签到 ,获得积分10
46秒前
科研通AI6.3的应助被甜美幻露采纳,获得10
49秒前
情怀的应助被科研通管家采纳,获得10
49秒前
一期一会发布了新的文献求助10
49秒前
我是老大的应助被科研通管家采纳,获得10
49秒前
孤独的神完成签到 ,获得积分10
50秒前
大模型的应助被科研通管家采纳,获得10
50秒前
秋风的应助被科研通管家采纳,获得10
50秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8195022
求助须知:如何正确求助?哪些是违规求助? 9580753
关于积分的说明 21872568
捐赠科研通 7794759
什么是DOI,文献DOI怎么找? 3437852
关于科研通互助平台的介绍 2561176
邀请新用户注册赠送积分活动 2484546